Cancer chemotherapy and pharmacologyHumansOximesThyroid NeoplasmsMalePyridones
Tumor response and thyroglobulin change in differentiated thyroid carcinoma treated with dabrafenib plus trametinib.
Haruhiko Yamazaki, Nobuyasu Suganuma, Mei Kadoya, Katsuhiko Masudo, Soji Toda, Aya Saito
Published: 202510.1007/s00280-025-04824-2
Abstract
PURPOSE: It has been reported that treatment response does not necessarily correlate with the change of thyroglobulin (Tg) during dabrafenib treatment in differentiated thyroid carcinoma (DTC). This study aimed to assess the association between the c…
Preview only. Read the full abstract at the source